Clinical Trial Update: A Phase 1b/2 Study of AMG 655 in Combination With Paclitaxel and Carboplatin for the First-Line Treatment of Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1b/2 study evaluated AMG 655 with paclitaxel and carboplatin as first-line therapy for advanced Non-Small Cell Lung Cancer, and the trial is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• AMG 655 (AMG-655)
• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Amgen | Conditions: Non-Small Cell Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED